Tetra Pharm opens new headquarters to boost cannabinoid drug research and manufacturing
16 Aug 2023
Danish biotech Tetra Pharm Technologies has completed the construction of a new facility in Scandinavia so it can push through with its long-term growth plans.
The 43,000-square-foot plant is in Medicon Valley, situated in the Greater Copenhagen region and Southern Sweden. The building itself was previously a manufacturing facility for medical device firm Ambu.
Copenhagen-based Tetra Pharm is looking to boost its R&D, specifically on cannabinoid-based drugs for neuropathic pain, sclerosis and mental health disorders. The site will also help it increase its manufacturing and production capacity, Tetra Pharm said in a press release.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.